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SUMMARY 
Epidemiological studies show clearly that Caesarean birth, perinatal or neonatal irrational antibiotic use is strongly 
associated with increased risk of obesity and diabetes in later life. Irrational use of antibiotics is a great global public 
health concern especially in developing economies like Ghana due to poor regulation on medicines. Unfortunately, 
this concern has been reduced to the fear of development of resistant organisms and the destruction of the world’s 
limited range of antibiotics therapy at the expense of other insidious risks including the development of metabolic 
and atopic diseases. These risks however appear to have greater implications on public health systems of developing 
economies. Here, we review the ignored role of antibiotics in the global obesity pandemic and project the risk that it 
poses to the health system of a developing economy like Ghana. 
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INTRODUCTION 
The biggest challenge of health systems of many devel-
oping economies is the management of communicable 
diseases. Malaria still accounts for more than 40% of 
out-patients attendances in Ghana1 and takes a greater 
part of the health budgetary resources. Although com-
municable diseases remain the main threat to health of 
developing countries, non-communicable diseases kill 
more people in the developing world.2 In addition, it has 
been shown that rising incomes in these developing 
countries will stimulate rises in non-communicable dis-
eases due to increased caloric intake, sedentary lifestyle, 
rapid nutrition transition and migration from rural to 
urban areas.  
 
Nutrition transition, the shift from traditional diet to 
Western diets consisting more of processed foods, fat, 
and fructose, is fuelled by commercialization of the 
food trade3,4 and many previously deprived regions of 
the world now have high accessibility to western diets. 
To these regions, commercialization of the food trade 
promotes food security but this may enhance the devel-
opment of non-communicable diseases. Furthermore the 
deliberate introduction of high amounts of fructose into 
the diet is a potential source of concern as fructose un-
like glucose is preferentially metabolized more into fat 
in the liver, leading to increased insulin resistance and 
visceral adipose tissue5,6 which are harbingers for diabe-
tes and other metabolic syndromes.  
 
Western lifestyle associated with increased alcohol and 
tobacco consumption7,8,9 partly due to aggressive mar-
keting is a risk in the development of diabetes and other 
metabolic diseases. Subsequently, by the year 2030, 
non-communicable diseases will overtake communica-
ble in many developing economies. Diabetes alone will 
increase by 150% in developing countries within that 
period.10  
 
While the trends in diabetes in developing economies 
share some resemblance to trends seen earlier in the 
developed world, the projected absolute numbers of 
people to develop diabetes and other metabolic syn-
dromes will overwhelm the health systems of these 
countries. Characteristically, diabetes and other meta-
bolic diseases in developing economies affect people 
mostly in their productive years compared to much old-





                                                                                                                                                                               
www.ghanamedj.org  Volume 50 Number 2 June 2016 108 
Furthermore, low incomes, severe limitations of health 
resources and illiteracy will confound strategies that 
have worked in the developed world.  
 
In view of the anticipated economic burden of therapeu-
tic management of non-communicable diseases, there is 
the urgent need to use preventive strategies such as life-
style changes and other public health interventions. 
 
The precipitous rise in the prevalence of diabetes and 
other metabolic syndromes in the developing world, 
particularly in Southeast Asia, presuppose that perhaps 
the idea of high caloric diet (Western diet) consumption 
and sedentary lifestyle as the only cause may be too 
simplistic and insufficient to completely explain the 
trends. To support these assertions, several hypotheses 
have been proposed. Earlier suggestions had focused on 
racial and genetic susceptibility,13 typically initiated by 
the propounding of “Thrifting gene” hypothesis by 
Neel14 and other subsequent modifications.  
 
However, other evidence suggests that common thera-
peutic agents like antibiotics may pre-dispose individu-
als to obesity and metabolic syndrome and may account 
partly for the rise in obesity-related diseases including 
cardiovascular and cerebrovascular accidents. Epidemi-
ological studies show clearly that irrational antibiotic 
use is associated with increased risk of obesity, diabetes 
and asthma in later life.15 It appears that the average 
clinician may not be conscious of how a seemingly 
harmless action of inappropriate antibiotic usage can 
contribute to the global obesity pandemic and increased 
incidences of metabolic diseases. This review focuses 
on the apparent insidious role chronic and irrational 
antibiotic use may play in the increased obesity in the 
Ghanaian society using data from countries that are al-
ready suffocating under the stress of increased metabol-
ic disorders. 
 
Global changes in human body stature-Impact on 
health and the role of environmental chemicals 
The physical condition of the human stature has being 
changing. Humans are now taller and bigger than they 
used to be two decades ago. In February 2014, the peo-
ple’s liberation army of China reported average increase 
in height and weight of Chinese soldiers over that of 
two decades ago. The US population has consistently 
grown taller from 1964. Epidemiological studies pro-
pose some health benefits for increased heights of a 
population, which include improved cardiovascular 
function16. However, this benefit will be nullified by the 
increased body weight. On the other hand, increased 
population height is associated with increased Ischemic 
Heart Diseases.17 Other data even suggest that shortness 
is associated with longevity and reduced risk of some 
cancers.17,18 Interestingly, some historic and current 
clinical data show that antibiotics may be influencing 
our bodies significantly which may be predisposing 
humans to diabetes, ischaemic heart diseases and can-
cers. 
 
Antibiotics and weight gain - a case for use in agri-
culture 
Antibiotics form a backbone of the multimillion global 
poultry industry. First demonstrated by 
Jukes,19antibiotics promote growth of vertebrates by 
enhancing the efficiency of conversion of feed to meat.  
Several other scientists corroborated Jukes results and 
subsequently antibiotics were introduced into agricul-
ture as growth promoters.20Compared to human health, 
agriculture consumes more than 80% of all antibiotics 
produced.21,22,23,24 Antibiotic treated animals have al-
tered gut anatomy and physiology including reduced 
intestinal weight and length,25,26 thinner intestinal epi-
thelium, high efficiency in nutrient absorption and re-
duced metabolic demands of the gastrointestinal sys-
tem.21 
 
It had been previously thought that the effect of antibi-
otics were due to the ability of sub-therapeutic doses to 
control subclinical infections. This was plausible be-
cause poultry raised in germ-free environments do not 
respond to the growth promoting effects of antibiotics 
but grow faster and more efficiently and exhibit feed 
efficiencies approaching those of antibiotic-treated 
poultry.27,28  However, it has been established that the 
enhanced growth, although independent on the kind of 
antibiotic used; was more pronounced in antibiotics that 
were rarely absorbed from the intestines. Consequently, 
conventional antibiotic mechanisms such as inhibition 
in specific microbial cellular or organelle functions have 
not been implicated but rather the effects of antibiotics 
in killing or inhibiting gut microflora growth. 
 
Consistent in both humans and animals are the altera-
tions in gut microflora of treated subjects. The current 
general consensus is that gut microflora; commonly 
referred to as the microbiome, were involved in pro-
gramming the metabolism and the immunity of the indi-
vidual29,30 and early perturbations may affect size and 
immunity which may be very beneficial in agriculture 
but detrimental in human health. 
  
Antibiotics and the obesity pandemic 
It has been noted that babies born by caesarian section 
are more likely to be prone to obesity in later life than 
those born by natural means.31  The main explanation to 
this observation is that the acquisition of microorgan-
isms from the birth canal of mothers appears to regulate 
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Similarly, exposure to antibiotics during the first 6 
months of life is associated with increase in body mass 
from 10 to 38 months28 and an increased risk of being 
overweight in children before age 7.33 Several experi-
ments, many unpublished because of ethical reasons, 
show that exposing children to antibiotics caused in-
creases in weight.  
 
Kalliomäki et al.34 has shown that 40% of overweight 
children had received antibiotics in infancy against 13% 
in the normal-weight group by the age of 6 months. Alt-
hough there is no available data on antibiotic consump-
tion amongst Ghanaian children, it is known that at least 
in the US children are prescribed on average about one 
course of antibiotics every year, often for ear and chest 
infections.35 Similar trends are likely to be seen amongst 
urban and affluent Ghanaian children. Interestingly, 
more than half of antibiotics prescribed to children are 
deemed irrational and unnecessary.  
 
Trends in antibiotic usage show increases and correlates 
very well with economic status of the population. It has 
been reported that the emerging economies of Brazil, 
Russia, India, China, and South Africa (BRICS) alone 
account for more the 70% for these rising trends in the 
past decade.36 This makes it difficult to exclusively 
evaluate the effects of antibiotics on human weight 
without high caloric diet, in particular fructose and sed-
entary lifestyles which are confounding factors. Alt-
hough many of these studies have been in children, lim-
ited data from adults show similar patterns. In an un-
published experiment involving US Naval recruits, it 
was established that supplementation with antibiotics 
resulted in increased body mass. Thuny et al., (2010)37 
reported that treating adults with vancomycin and gen-
tamicin combination, two antibiotics that are poorly 
absorbed from the intestines, for endocarditis was sig-
nificantly linked to development of obesity within a 
year.  
 
To understand the interaction between high caloric diet 
and antibiotic therapy, Cho et al.38 simulated experi-
ments in mice where animals received a high caloric 
diet alone or in combination with antibiotics. Antibiotic-
treated mice gained twice the weight of untreated mice. 
Interestingly, the effects were greater amongst female 
animals than male. After antibiotic use, changes in the 
expression of gut microbial genes involved in metabo-
lism of carbohydrates into short-chain fatty acids were 
observed with enhanced expression in genes involved in 
storing unused calories as lipids.  
 
The diabetes epidemic in China  
Type 2 diabetes has reached epidemic proportions in the 
general adult population in China.39 The National Dia-
betes Research Group of China says that, just over two 
decades ago Type 2 was so rare in China that less than 
1% of the population had the disease.  
Today diabetes has reached alarming rates with more 
that 11% of the population having diabetes and approx-
imately 500 million people having pre-diabetes; abnor-
mally high hyperglycaemia but not high enough for a 
diagnosis. Interestingly, in China as in other Asian 
countries, obesity does not correspond so well with the 
development of diabetes; as diagnosis occurs at a much 
lower BMI of 23.7 kg/m² compared to 27 kg/m² in other 
populations.41,42 Researchers believe that there is a ten-
dency among East Asians to accumulate belly fat (high-
er visceral adipose fat) which is a predisposing factor to 
the development of Type 2 diabetes.42 Genetic predispo-
sition as well as high caloric diet and increasing seden-
tary lifestyle have been proposed to be the causes of the 
increases in diabetes.13 So far, no diabetic gene exclu-
sive to Chinese or Asians has been reported. Although 
Western food consumption is growing rapidly amongst 
Chinese it still has not reached a huge proportion of the 
population to be solely responsible for these increases. 
Other East Asian countries that share similar genetic 
makeup and consuming high caloric diets as some Chi-
nese are also experiencing increases in the incidence of 
diabetes but have not reached endemic rates. Moreover, 
globally there are countries that consume more calories 
and are less active than Chinese and yet diabetes has not 
reached such alarming rates. It is known that people 
living in cities and urban areas, tend to be less physical-
ly active partly because of mechanization of transport 
and white collar jobs and have high risk of obesity and 
diabetes. A Chinese study showed that diabetes preva-
lence differed in regions with economic status; however 
the prevalence of diabetes was similar between urban 
residents and rural residents in economically developed 
regions implying that there may be more to it than the 
presumed sedentary lifestyles.41 
 
China’s abnormal antibiotic consumption 
Data on antibiotic consumption in China is unprece-
dented in the world. China has become the world's lead-
ing antibiotics consuming country, with an average con-
sumption of 138 grams per person per year. Literally, 
the average Chinese now consumes ten times the antibi-
otic of an average American. Over 50% of outpatient’s 
prescriptions from Chinese hospitals contain at least one 
antibiotic.51,52 This is in contrast to the US where only 
15% of prescriptions have an antibiotic.53 According to 
data from the World Health Organization, up to 80% of 
all hospital admissions in China receive some type of 
antibiotic and broad-spectrum antibiotics and multiple 
antibiotic courses account for 58%.54 This figure is 
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China along with four other countries currently account 
for more than 76% of the increase in global antibiotic 
consumption between 2000 and 2010.36  
Data from animal studies have shown that there is an 
association between antibiotic consumption and accu-
mulation of visceral adipose fat. Visceral adipose fat is a 
risk in the development of diabetes. Some Chinese pa-
tients at diagnoses for diabetes have normal BMI but 
high visceral adipose fat.  
 
Diabetes in Ghana 
The earliest available post-independence data shows 
that prevalence was 0.2% of the population in 196443 
and this has increased steadily over the years. A Ghana 
Diabetes Association study showed that between 1990 
and 2000 prevalence increased from  2-3% to 6.4%.44 
Most of the increases occurred in urban centers with 
over 10.7% of the population having impaired glucose 
tolerance. The number of people with diabetes in Ghana 
is expected to double by 2030.45,46 Additionally, it is 
reported that in Ghana due to some sociocultural prac-
tices and beliefs as well as rapid urbanization, there are 
indications that diabetes incidence in the Kumasi Me-
tropolis, for example, amongst the adult population 
alone may be higher than many urban areas of Sub-
Saharan Africa.47,48 Further projections by Mbanya et 
al.49 indicate that diabetes-related morbidity and mortal-
ity in Ghana will increase dramatically in the coming 
years. The cost of managing diabetes in Ghana has in-
creased steadily from $180 – $420 in 2000 to $106 – 
$638 in 2007 per year.50 These figures exclude other 
cost in managing comorbidities such as dialysis in renal 
failure and hypertension. It is plausible that explosion in 
diabetes incidence in Ghana as pertains in South-East 
Asia may excessively increase the health budget, threat-
en the national insurance system and overwhelm Gha-
na’s fragile economy. However, since approximately 
90% of reported diabetes cases in Ghana are type 2, 
intensive public health education and appropriate inter-
ventions could salvage and reverse the current trend. 
 
Ghana’s antibiotic consumption 
Due to poor drug regulation, data on antibiotic con-
sumption patterns in Ghana is limited although antibiot-
ics remain readily available in health facilities across the 
country and can easily be obtained without authoriza-
tion from a qualified prescriber. Indeed the incidences 
of antimicrobial resistance and treatment failures give 
clear indications of irrational use of antibiotics. A report 
by Donkor et al.55 indicates that about 30% of tertiary 
students in Accra take an antibiotic within a month. In 
the same study 70% of respondents had self-medicated 
without a prescription. A study in the Cape Coast me-
tropolis showed that over 70% of respondents obtained 
antibiotic without prescription.56 Consistently, amoxicil-
lin, a broad spectrum antibiotic, accounts for more than 
50% of antibiotics obtained without prescription in 
Ghana.  
Respiratory conditions such as colds and coughs ac-
count for a chunk of the diseases for which antibiotics 
are used in Ghana.55,56  
 
Furthermore, with the recent introduction of pre-school 
in Ghana, and more mothers taking up jobs, baby res-
piratory infections are also expected to increase, which 
most invariably are managed with aggressive antibiotic 
therapy, even though many of these infections such as 
common cold are of viral origin and do not require anti-
biotic therapy. In line with this reasoning, infant antibi-
otic exposure may be underestimated. 
 
The Thrifty genotype explained with antibiotics 
Neel in 1962 attempted to explain why some people or 
populations were more susceptible to the development 
of diabetes through genetics and natural selection14. He 
proposed that early in the evolution of man when fam-
ine, as selective pressure, was predominant, inheritance 
of diabetes predisposing genes called “THRIFTY 
GENES” were beneficial in enhancing efficiency of 
conversion of food into fat for storage in anticipation of 
harder times. However these genes became a disad-
vantage in the modern world where famine is rare and 
food is readily available. 
 
This hypothesis has been widely used to explain why 
some populations have high rates of diabetes. Unfortu-
nately, years of research have not been able to identify 
the so called “THRIFTY GENES”57 and this has led to 
modifications and/or abandoning of the hypothesis. 
However, factoring in the role of antibiotics, whose use 
gained more grounds in health around the time the hy-
pothesis was postulated, the hypothesis becomes more 
compelling. The evidence presented here so far shows 
that antibiotics enhance the efficiency of conversion of 
food to fat for storage which in the hypothesis is due to 
“THRIFTY GENES”. Exposures to antibiotics promote 
expression of several genes involved in carbohydrate 
metabolism. It may be suggested that Neel’s “THRIFTY 
GENES” are not more than genetic modification that 
occurs due to antibiotic exposure that promotes food 
utilization. 
 
Chinese and Ghanaian Health systems parallelism 
The Chinese health system is failing in its effort to con-
trol diabetes. It is said that for every new diagnoses of 
diabetes in China, two other people (70%) remain undi-
agnosed.58,59 Ghana’s health system cannot be said to be 
a miniature of the Chinese, however, there are some 
structural and policy driven features that resembles the 
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Most health facilities in China are owned and operated 
by the government. In order to enhance accessibility and 
affordability without compromising quality, the gov-
ernment (central, city, provincial) publishes the prices 
of services just like the National Health Insurance Au-
thorities in Ghana. Hospitals in China are unable to 
meet their budgetary requirements and rely heavily on 
drug sales to meet their needs.  
 
The Chinese government has reduced subventions to 
public hospitals and it is estimated that only 20% of 
hospitals income comes from the government.60,61,62 To 
stay afloat, facilities guided by profitability under pro-
vide, split or over-provide certain services to increase 
their revenue.63,64 Prescribers on their part are pressur-
ized to prescribe medicines irrationally to meet the 
budget deficits and over half of hospital spending by 
patients is on pharmaceuticals.65 Like China, some 
pharmaceutical companies in Ghana also induce pre-
scribers to prescribe their products to boost the sale of 
their products.66 National data show that 60% of hospi-
tals’ revenue is generated by selling drugs and 30–40% 
of drug consumption represented inappropriate utiliza-
tion in China.67 In Ghana, government subventions are 
inadequate and insurance claims are delayed for a con-
siderable period in the fiscal year. Hospitals are forced 
to rely on internally generated funds which may include 
increased drug sales.  
 
Retail pharmacy practice is poorly developed in China 
and the practice of prescribing and dispensing is not 
distinct and clearly separated. Similarly in Ghana, The 
National Health Insurance Scheme does not decouple 
prescribing practices from dispensing practices. This 
breeds conflict of interest and promotes irrational anti-
biotic prescribing and usage. The National Health Insur-
ance of Ghana like the Chinese government also does 
not pay dispensing fee as pertains in many countries67, 
but rather retail pharmacists and dispensers earn their 
income from the difference between the wholesale and 
retail prices. This does not motivate pharmacists to 
monitor irrational use of antibiotics since they stand to 
benefit from such practices. 
 
The psyche of Chinese patients is such that they are 
likely to request for antibiotics from their General Phy-
sician even when in the opinion of the practitioner anti-
biotic use may be unnecessary. In Ghana, one of the 
objectives of the Ghana National Drug Programme 
(GNDP) is to promote the rational use of medicines. In 
spite of the efforts made by the programme, antibiotics 
are easily obtained from pharmacies without prescrip-
tion.68 Drug regulation especially Class A and B drugs 
is a problem and several unlicensed and unaccredited 
persons dispense antibiotics to the general public. The 
Food and Drugs Authority (FDA) in Ghana  and the 
Ghana Pharmacy Council are under resourced to regu-
late the rational use of medicines. There are efforts by 
several non-governmental organizations to promote 
rational drug use. For example, the Antibiotic Drug Use, 
Monitoring and Evaluation of Resistance in Ghana 
(ADMER), a Ghana-Denmark initiative aims at building 
research capacity to help combat irrational antibiotic 
use. The efforts of government agencies including the 
FDA, GNDP and non-governmental organizations to-
wards the rational use of antibiotics should be stepped 






Ghana’s economic growth has improved over the cur-
rent decade. Rapid economic growth is associated with 
increased antibiotic consumption as well as increased 
metabolic and cardiovascular diseases. In view of the 
overwhelming evidence implicating antibiotic consump-
tion to increased obesity and other metabolic related 
diseases, there is the urgent need to strictly enforce the 
regulations on the use of antibiotics in Ghana. With 
current trends, irrational antibiotic use in Ghana can 
only be expected to increase in the coming years. There-
fore diabetes and other related metabolic diseases are 
expected to increase.  The solution as has been empha-
sized elsewhere is lifestyle modification with active 
education for the promotion of rational antibiotic use. In 
practical terms, rational use of antibiotics will require 
that patients receive appropriate antibiotics, preferably 
narrow spectrum that meet their specific clinical needs, 
in the right doses for the appropriate duration at a rea-
sonable cost. The long-term effects of irrational antibi-
otic use may be a price too costly for our fragile health 
system to bear. A multifaceted approach including edu-
cation of clinicians, doctors, pharmacists, nurses and 
patients and adherence to rational prescribing and dis-
pensing in Ghana as well as monitoring should provide 
the framework for the quest to reverse these trends. 
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